209 related articles for article (PubMed ID: 12601227)
1. A self-controlled, naturalistic study of selective serotonin reuptake inhibitors versus tricyclic antidepressants.
Faravelli C; Cosci F; Ciampelli M; Scarpato MA; Spiti R; Ricca V
Psychother Psychosom; 2003; 72(2):95-101. PubMed ID: 12601227
[TBL] [Abstract][Full Text] [Related]
2. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Zohar J; Westenberg HG
Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
[TBL] [Abstract][Full Text] [Related]
5. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
6. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Montgomery SA; Judge R
Acta Psychiatr Scand Suppl; 2000; 403():9-16. PubMed ID: 11019930
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with depression associated with anxiety symptoms.
Nutt D
J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
12. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
13. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
Steffens DC; Krishnan KR; Helms MJ
Depress Anxiety; 1997; 6(1):10-8. PubMed ID: 9394870
[TBL] [Abstract][Full Text] [Related]
14. The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?
Nierenberg AA
J Clin Psychiatry; 1994 Sep; 55 Suppl A():55-9; discussion 60-1, 98-100. PubMed ID: 7961543
[TBL] [Abstract][Full Text] [Related]
15. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
17. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders.
de Kemp EC; Moleman P; Hoogduin CA; Broekman TG; Goedhart A; Schaap CP; van den Berg PC
Psychopharmacology (Berl); 2002 Feb; 160(1):67-73. PubMed ID: 11862375
[TBL] [Abstract][Full Text] [Related]
19. Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jämtland county, Sweden, 1995.
Henriksson S; Boëthius G; Håkansson J; Isacsson G
Acta Psychiatr Scand; 2003 Dec; 108(6):427-31. PubMed ID: 14616223
[TBL] [Abstract][Full Text] [Related]
20. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis.
Bakker A; van Balkom AJ; Spinhoven P
Acta Psychiatr Scand; 2002 Sep; 106(3):163-7. PubMed ID: 12197851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
